Skip to main content

Table 2 Radiotherapy and dosimetric parameters

From: Multifocal high-grade glioma radiotherapy safety and efficacy

Pat

RT Plan

Dose (Gy)

Conc. Ctx

Adj. Ctx

GTV Sum (ccm)

PTV (ccm)

Brain (ccm)

PTV/brain ratio (%)

Mean brain dose (Gy)

D2 Brain (Gy)

V30 Brain (%)

V45 Brain (%)

Treatment at progression

1

3D CRT

60

TMZ

TMZ

67.2

654.1

1554.9

42.1

44.3

61.5

74.1

64.1

BSC

2

3D CRT

60

TMZ

TMZ

20.1

446.8

1252.7

35.7

37.9

61.5

62.3

53.5

BSC

3

3D CRT

59.4

TMZ

none

48.6

573.8

1464.5

39.2

38.3

60.2

68.4

53.5

BSC

4

3D CRT

59.4

TMZ

TMZ

39.8

544.3

1435.1

37.9

37.4

62.1

58.3

49

BSC

5

3D CRT

59.4

TMZ

none

10

567.3

1179

48.1

37.6

60.1

61.6

48.7

BSC

6

3D CRT

60

TMZ

TMZ

16.7

435.5

1388.8

31.4

37.2

61.3

54.4

41.8

BSC

7

IMRT

60

TMZ

TMZ

58

833.8

1466.1

56.9

43

60.7

79.3

53.8

BSC

8

IMRT

60

TMZ

none

113.6

578.3

1372.5

42.1

42.5

62.7

68.4

46.7

BEV/IRI

9

IMRT

60

TMZ

TMZ

21.9

415.9

1410.9

29.5

40.1

62.5

66

49.2

BSC

10

IMRT

55

none

none

24.9

516.1

1355.4

38.1

31.5

57.4

52.5

32.2

BEV/IRI

11

VMAT

60

TMZ

none

89.3

349.5

1458.7

24

36.8

60.4

63.9

39.2

BSC

12

VMAT

50

BEV

BEV

303.9

888.5

1406.5

63.2

36.4

51.2

79.7

14.9

BSC

13

VMAT

60

TMZ

none

16.9

333.2

1285.2

25.9

32.5

61.8

56.1

34.2

BSC

14

VMAT

60

TMZ

TMZ

3.6

290

1241.4

23.4

30.8

62

40.8

29.2

ReRT + TMZ

15

VMAT

60

TMZ

CeTeG

13.3

192.6

1451.2

13.3

27.9

61.5

34.3

23.7

NA

16

3D CRT

60

TMZ

none

23.7

373.25

1175.1

31.8

39.7

61.7

61.5

48.9

BSC

17

VMAT

60

CeTeG

CeTeG

27.1

203.4

1599.6

12.7

25.3

61.7

33

21

TMZ

ReRT GLIAA

18

VMAT

60

TMZ

TMZ

39.6

400.8

1187.1

33.8

36.1

61.8

56.5

39.6

BSC

19

VMAT

60

TMZ

TMZ

27.4

375.6

1410.8

26.6

31.9

62.1

44.6

33.6

BSC

20

VMAT

60

none

none

12.5

161.6

1342.1

12

31.4

61.4

42.1

21.2

BSC

Median

NA

60

NA

NA

26

425.7

1397.65

32.8

37

61.5

59.9

40.7

NA